Trimb acquires established European OTC products

On 28 June Trimb Healthcare AB completed the acquisition of a portfolio of well-established European OTC products from Cilag GmbH International and Janssen Pharmaceutica NV (collectively, “J&J”). The portfolio includes products such as Pevaryl®, Fungoral®, Gyno-Pevaryl® and Epi-Pevaryl®, and is based on the active substance econazole nitrate and ketoconazole, which treat fungal infections of the skin.